Plus Therapeutics Profit Margin

As of the most recent data (March 2026), PSTV shows a profit margin of 485.79%. That compares with -1159.88% in the prior-year period — up 141.9% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PSTV's profit margin is now 485.79% (was -1159.88%) — a 141.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Plus Therapeutics is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Plus Therapeutics is at 485.79%, which is higher that average. That is roughly 3286.5% above the sector mean. Use the comparison chart on this page to see how PSTV stacks up against individual peers as well.

That compares with -1159.88% in the prior-year period — up 141.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Plus Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Plus Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 485.79%) with ownership activity and broader fundamentals.